Randomized parallel controlled trial of 'on demand' therapy versus continuous therapy of omepral 20mg in effectiveness and safety for the patients {Los Angeles classification grade M (LA M) or more)} diagnosed as the gastroesophageal reflux disease.

Trial Profile

Randomized parallel controlled trial of 'on demand' therapy versus continuous therapy of omepral 20mg in effectiveness and safety for the patients {Los Angeles classification grade M (LA M) or more)} diagnosed as the gastroesophageal reflux disease.

Completed
Phase of Trial: Phase III

Latest Information Update: 08 Jul 2013

At a glance

  • Drugs Omeprazole (Primary)
  • Indications Gastro-oesophageal reflux
  • Focus Therapeutic Use
  • Most Recent Events

    • 31 May 2013 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan record.
    • 21 May 2013 Results presented at the Digestive Disease Week 2013.
    • 07 Dec 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top